| Identification | Back Directory | [Name]
(1R,5R,6R,7S)-rel-4-Oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylicacid6,7-dimethylester | [CAS]
960201-81-4 | [Synonyms]
SD 1008
dimethyl (1R,5R,6R,7S)-8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylate
(1R,5R,6R,7S)-rel-4-Oxo-8-(phenylmethyl)-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylicacid6,7-dimethylester | [Molecular Formula]
C18H19NO5 | [MDL Number]
MFCD18086855 | [MOL File]
960201-81-4.mol | [Molecular Weight]
329.35 |
| Chemical Properties | Back Directory | [Boiling point ]
465.3±45.0 °C(Predicted) | [density ]
1.279±0.06 g/cm3(Predicted) | [storage temp. ]
Store at RT | [solubility ]
Soluble to 100 mM in DMSO and to 5 mM in ethanol | [form ]
Powder | [pka]
1.96±0.60(Predicted) | [color ]
Light yellow to yellow |
| Hazard Information | Back Directory | [Uses]
SD 1008 is a novel JAK2 inhibitor, which increases chemotherapy sensitivity in human ovarian cancer cells. | [IC 50]
JAK2; STAT3 | [storage]
Store at RT |
|
|